Heart Failure
REHAB-HF: Rehabilitation program improves physical function in older adults with HF
Older adults hospitalized for acute HF who participated in a progressive 12-week rehabilitation program had better outcomes compared with those receiving standard care, according to results of the REHAB-HF trial.
PARAGON-HF: Sacubitril/valsartan reduces triglyceride levels in HFpEF
Sacubitril/valsartan drastically reduced triglycerides compared with valsartan in patients with HF with preserved ejection fraction, according to a presentation at the American College of Cardiology Scientific Session.
Marked health status improvement with mavacamten in obstructive hypertrophic cardiomyopathy
The cardiac myosin inhibitor mavacamten substantially improved health status in patients with symptomatic obstructive hypertrophic cardiomyopathy, with benefits observed early after treatment, according to new data from EXPLORER-HCM.
Sacubitril/valsartan not superior to ramipril for prevention of HF, death after MI
Sacubitril/valsartan did not significantly reduce the rate of CV death, HF hospitalization or outpatient HF requiring treatment following acute MI compared with ramipril, according to results of the PARADISE-MI trial.
Certain prostate cancer treatments may increase risk for HF, MI, arrhythmias
Abiraterone and gonadotropin-releasing hormone agonists for the treatment of prostate cancer may increase the likelihood of drug-related adverse cardiac events, according to data published in EClinicalMedicine.
Hypertension tied to higher risk for HF, AF in patients with no history of CVD
Elevated BP and stage 1 and stage 2 hypertension were associated with a greater frequency of HF, atrial fibrillation and other CVDs compared with normal BP in the general population, according to a study published in Circulation.
First-phase EF confers greater risk for death in hospitalized patients with COVID-19
Among hospitalized patients with COVID-19, those with reduced first-phase ejection fraction were more likely to die compared with patients with normal first-phase EF, researchers reported.
Top in cardiology: Barbershop BP intervention, new HF definition
Researchers found that a pharmacist-led intervention for hypertension care at Black-owned barbershops was highly cost-effective. A review of the findings was the top story in cardiology last week.
ACC, HealthReveal collaborate to improve guideline-directed treatment of HFrEF using AI
The American College of Cardiology and HealthReveal, an artificial intelligence company, announced a collaboration to employ HealthReveal’s personalized clinical AI solution to the ACC’s TRANSFORM studies.
Pneumonia incidence elevated in patients with HF, particularly HFpEF
Pneumonia incidence was high in patients with HF and especially high in those with HF with preserved ejection fraction, according to new data from the PARADIGM-HF and PARAGON-HF trials.